Steward Partners Investment Advisory, LLC 89bio, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 20,210 shares of ETNB stock, worth $128,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,210
Previous 80,360
74.85%
Holding current value
$128,939
Previous $594,000
73.91%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ETNB
# of Institutions
173Shares Held
124MCall Options Held
78.7KPut Options Held
979K-
Janus Henderson Group PLC London, X016.5MShares$105 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$90.4 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$65.1 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$47.7 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$44.8 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $297M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...